HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delta +-thalassemia in Sardinia.

Abstract
We have defined a new type of delta-thalassemia in which beta-globin chain synthesis is incompletely suppressed. Homozygotes have unusually low HbA2 levels, and double heterozygosity for this delta-thalassemia gene and beta-thalassemia normalizes the HbA2 level. The delta-thalassemia occurs on a chromosome that is identifiable using polymorphic restriction endonuclease sites. We call this condition delta +-thalassemia, to distinguish it from the previously described delta 0-thalassemia syndromes in which no delta-globin chain synthesis occurs.
AuthorsM Pirastu, R Galanello, M A Melis, C Brancati, A Tagarelli, A Cao, Y W Kan
JournalBlood (Blood) Vol. 62 Issue 2 Pg. 341-5 (Aug 1983) ISSN: 0006-4971 [Print] United States
PMID6307432 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Hemoglobins, Abnormal
  • Hemoglobin A2
  • DNA Restriction Enzymes
Topics
  • Chromosome Mapping
  • DNA Restriction Enzymes (metabolism)
  • Hemoglobin A2 (biosynthesis)
  • Hemoglobins, Abnormal (biosynthesis)
  • Heterozygote
  • Homozygote
  • Humans
  • Italy
  • Male
  • Pedigree
  • Thalassemia (blood, epidemiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: